Безопасен ли origanum majorana leaf extract при беременности?
No harmonised CLP reproductive classifications for Origanum majorana leaf extract and no SCCS/CIR safety assessment identifying reproductive risks. PubMed literature does not show human teratogenic or reproductive toxicity data for the extract; botanical constituents (terpenes, phenolics) do not individually trigger harmonised reproductive flags. Dermal absorption from topical use is expected to be low but measurable, so exposure is scored as low (evidence: CosIng/ECHA entries list the extract without restrictions; PubChem lists constituent volatiles but no reproductive alerts).
Pregnancy-safe products containing origanum majorana leaf extract










Related ingredients
Frequently asked questions
- Безопасен ли origanum majorana leaf extract при беременности?
- No harmonised CLP reproductive classifications for Origanum majorana leaf extract and no SCCS/CIR safety assessment identifying reproductive risks. PubMed literature does not show human teratogenic or reproductive toxicity data for the extract; botanical constituents (terpenes, phenolics) do not individually trigger harmonised reproductive flags. Dermal absorption from topical use is expected to be low but measurable, so exposure is scored as low (evidence: CosIng/ECHA entries list the extract without restrictions; PubChem lists constituent volatiles but no reproductive alerts).
- Безопасен ли origanum majorana leaf extract при грудном вскармливании?
- No evidence of reproductive or lactation-specific toxicity in authoritative sources. No harmonised classification or SCCS/CIR concern. Potential for low dermal absorption exists, but no data showing transfer into breastmilk; exposure scored as low (CosIng/ECHA/PubChem; absence of CIR/SCCS warnings).
- Безопасен ли origanum majorana leaf extract для кожи малыша?
- No infant-specific safety signals or harmonised reproductive classifications. However, because infant skin has higher permeability and surface-area-to-weight ratio, exposure scoring is increased by +1 (adult e=1 → infant e=2). No data support increased hazard or a specific reproductive mechanism in infants.
- Как VeriMom оценивает origanum majorana leaf extract?
- VeriMom оценивает origanum majorana leaf extract в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы origanum majorana leaf extract при беременности?
- См. наш список безопасных альтернатив origanum majorana leaf extract с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.